Description

Hormone & Weight Support Supplement | Alani Nu Balance

Alani Nu can help balance your hormone levels as well as promote weight management! Alani Nu Balance will help to promote your overall Hormone balance, & comes in easy for on-the-go capsule form. Its formula contains L-Glutathione & many other powerful Antioxidants, & will help to promote weight management. On top of all of that, it ll help to improve your mood & provide you with a brighter complexion overall. If you re looking to control your hormone levels, clear your Skin, improve mood, and more, then you have got to try Alani Nu Balance!

Alani Nu Balance Benefits

• Helps To Promote Overall Hormone Balance
• Comes In Easy For On-The-Go Capsule Form
• Helps To Support Fetal Development
• Contains L-Glutathione & Other Powerful Antioxidants
• 100% Gluten & Vegan Free
• Promotes Weight Management
• Helps To Improve Mood & Overall Mental Cognition
• Supports Complexion & Brighter Skin

• How Do I Take Alani Nu Balance?

  Alani Nu recommends taking four (4) capsules with a morning meal. 

  Alani Nu Balance Side Effects & Warnings

  Do not exceed the recommended dosage. Consult your Physician before using this dietary supplement. Do not use this product if you are at risk or are being treated for high Blood Pressure, Kidney, Thyroid, or Psychiatric Disease, difficulty urinating, Prostate enlargement, Seizure disorder, or Stroke. Keep out of reach of children. Store in a cool, dry place. 

  References

  Prussick R, Prussick L, Gutman J. Psoriasis Improvement in Patients Using Glutathione-enhancing, Nondenatured Whey Protein Isolate: A Pilot Study. J Clin Aesthet Dermatol. 2013;6(10):23–26.

  https: pubmed.ncbi.nlm.nih.gov 24155989-psoriasis-improvement-in-patients-using-glutathione-enhancing-nondenatured-whey-protein-isolate-a-pilot-study

   

  Du H, Zhang X, Zeng Y, et al. A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF-α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT mTOR Signal Pathway. Front Immunol. 2019;10:1620. Published 2019 Jul 23. doi:10.3389 fimmu.2019.01620

  https: www.ncbi.nlm.nih.gov pmc articles PMC6663984